COAGULATION FACTOR VIIA RECOMBINANT HUMAN for Factor viii deficiency: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 130 adverse event reports in the FDA FAERS database where COAGULATION FACTOR VIIA RECOMBINANT HUMAN was used for Factor viii deficiency.
Most Reported Side Effects for COAGULATION FACTOR VIIA RECOMBINANT HUMAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 169 | 17.8% | 85 | 50 |
| Haemorrhage | 129 | 13.6% | 21 | 53 |
| Drug ineffective | 117 | 12.3% | 26 | 47 |
| Death | 85 | 8.9% | 85 | 8 |
| Pre-existing disease | 78 | 8.2% | 78 | 22 |
| Therapy partial responder | 78 | 8.2% | 76 | 23 |
| Acquired haemophilia | 72 | 7.6% | 70 | 23 |
| Haemarthrosis | 47 | 4.9% | 3 | 27 |
| Haematoma | 30 | 3.2% | 3 | 21 |
| Therapy responder | 30 | 3.2% | 27 | 22 |
| Thrombosis | 27 | 2.8% | 6 | 12 |
| Condition aggravated | 23 | 2.4% | 8 | 11 |
| Shock haemorrhagic | 20 | 2.1% | 14 | 8 |
| Epistaxis | 19 | 2.0% | 0 | 13 |
| Haemorrhage intracranial | 19 | 2.0% | 7 | 8 |
Other Indications for COAGULATION FACTOR VIIA RECOMBINANT HUMAN
Acquired haemophilia (244)
Product used for unknown indication (97)
Haemorrhage (92)
Prophylaxis (54)
Factor vii deficiency (51)
Haemophilia (44)
Haemophilia a with anti factor viii (43)
Factor ix deficiency (36)
Haemostasis (30)
Off label use (26)
Other Drugs Used for Factor viii deficiency
EMICIZUMAB-KXWH (6,532)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (4,268)
EFMOROCTOCOG ALFA (832)
--BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 (722)
ANTIHEMOPHILIC FACTOR, PEGYLATED HUMAN SEQUENCE RECOMBINANT (352)
ANTI-INHIBITOR COAGULANT COMPLEX (317)
EMICIZUMAB (315)
DAMOCTOCOG ALFA PEGOL (310)
EFANESOCTOCOG ALFA (292)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETED (180)